Replies to post #26907 on NanoViricides Inc. (NNVC)

[Smooth]

So, the timing to revenue is not necessarily tied to FDA approval and commercialization.

Agreed...same goes for the PPS...significant upside movement is not NECESSARILY tied to FDA approval and commercialization." IMO! We can go up a long way from here LONG BEFORE any drug hits the market. It's all about potential and the market for neutralizing viruses is basically UNLIMITED. IF/WHEN the street begins to figure this out, we'll be $10-15 per share IMO. I'll take a $3-4 per share per year increase for the next 3 years and be very happy...and well off too!